DNA topoisomerase inhibitors as antifungal agents.
Shen
L L
LL
Anti-infective Research Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
Fostel
J M
JM
D000935:Antifungal Agents / Q000494:pharmacology*; D001234:Aspergillus niger / Q000187:drug effects* / Q000201:enzymology; D002166:Camptothecin / Q000494:pharmacology; D002176:Candida albicans / Q000187:drug effects* / Q000201:enzymology; D004264:DNA Topoisomerases, Type I / Q000302:isolation & purification; D004250:DNA Topoisomerases, Type II / Q000302:isolation & purification; D005047:Etoposide / Q000494:pharmacology; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D012441:Saccharomyces cerevisiae / Q000201:enzymology; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors
D000935:Antifungal Agents; D059004:Topoisomerase I Inhibitors; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D004264:DNA Topoisomerases, Type I; D004250:DNA Topoisomerases, Type II; D002166:Camptothecin